Eagle Pharmaceuticals Stock (NASDAQ: EGRX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 141.55K |
Day Range | - - - |
52 Wk Range | 3.21 - 15.95 |
Market Cap | $49.63M |
P/E Ratio | 5.02 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 5.07% |
Days to Cover | 5.35 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Eagle Pharmaceuticals (NASDAQ:EGRX) through any online brokerage.
Other companies in Eagle Pharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Serina Therapeutics (AMEX:SER), HOOKIPA Pharma (NASDAQ:HOOK), Intensity Therapeutics (NASDAQ:INTS) and Barinthus Biotherapeutics (NASDAQ:BRNS).
Eagle Pharmaceuticals has a consensus price target of $17.00.
The stock price for Eagle Pharmaceuticals (NASDAQ: EGRX) is $4.27 last updated September 19, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Eagle Pharmaceuticals.
Eagle Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Eagle Pharmaceuticals.
Eagle Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.